Jens Juul Holst

Jens Juul Holst

Professor


  1. 1998
  2. Published

    The inhibitory effect of glucagon-like peptide-1 (7-36) amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36) amide.

    Wettergren, A., Wojdemann, M. & Holst, Jens Juul, 1998, In: Peptides. 19, p. 877-882

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus

    Jensen, P. B., Blume, N., Mikkelsen, J. D., Larsen, P. J., Jensen, H. I., Holst, Jens Juul & Madsen, O. D., 1998, In: J. Clin. Invest.. 101, p. 503-510

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Treatment of type 2 diabetes with glucagonlike peptide 1

    Holst, Jens Juul, 1998, In: Current Opinion in Endocrin. and Diabetes. 5, p. 108-115

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 4207